S 4629 — Amends telehealth and telemedicine law concerning prescription of Schedule II drugs to certain patients.
Last action — INT 1RS REF SHH
-
1Introduced
-
2In Committee
-
3Passed Senate
-
4Passed General Assembly
-
5To Executive
-
6Enacted
This bill has been introduced in the Senate. Introduced October 01, 2026. It must pass committee before a floor vote.
Next likely step: a committee referral and hearing.
Odds of enactment
Low chanceBased on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.
Upgrade to see the exact probability and what's driving it.
A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.
Prognosis
Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.
Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.
In plain language
The bill changes laws about prescribing Schedule II drugs via telehealth.
This bill modifies existing telehealth regulations to allow healthcare providers to prescribe Schedule II drugs to patients. It addresses the conditions under which these prescriptions can be made, impacting access to necessary medications.
What this means for you
- Healthcare: Healthcare providers may have more flexibility in prescribing essential medications through telehealth services.
Summary
Schedule II drugs-amend telehealth & telemedicine law concerning prescription
Bill Text
- Introduced View text Current html October 02, 2026
AI-generated reading aid from the bill's amendatory text — verify against the official bill.
This bill amends 1 section(s) of the New Jersey statutes: N.J.S.A. 45:1-62.
-
N.J.S.A. 45:1-62
controlled dangerous substances a in-person visit required every three months controlled dangerous substance a controlled dangerous substance→ controlled substances listed on at section 6 of P.L.1970, c.226 (C.24:21-6) any appointments scheduled at intervals clinically determined by the physician and patient substances as listed on at section 6 of P.L.1970, c.226 (C.24:21-6) listed on at section 6 of P.L.1970, c.226 (C.24:21-6)amended
Action History
-
INT 1RS REF SHH
Sponsors
- Gordon M. Johnson · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 119 not signed on
Sponsors (1)
- Johnson, Gordon M.
Co-sponsors (0)
None.
Not signed on (119)
119 members have not signed on to this bill.
Show all 119 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does S 4629 do?
- Schedule II drugs-amend telehealth & telemedicine law concerning prescription
- Who sponsors S 4629?
- S 4629 is sponsored by Johnson, Gordon M..
- What is the current status of S 4629?
- This bill has been introduced in the Senate. Introduced October 01, 2026. It must pass committee before a floor vote.
- Where can I track S 4629?
- Track S 4629 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on S 4629
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of S 4629
Last checked for changes 6 days ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →